0001632083-17-000001.txt : 20170724 0001632083-17-000001.hdr.sgml : 20170724 20170724160442 ACCESSION NUMBER: 0001632083-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170724 DATE AS OF CHANGE: 20170724 EFFECTIVENESS DATE: 20170724 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Alpine Immune Sciences, Inc. CENTRAL INDEX KEY: 0001632083 IRS NUMBER: 472667641 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-291377 FILM NUMBER: 17978384 BUSINESS ADDRESS: STREET 1: 600 STEWART ST. STREET 2: STE. 1503 CITY: SEATTLE STATE: WA ZIP: 98101 BUSINESS PHONE: (206)441-5064 MAIL ADDRESS: STREET 1: 600 STEWART ST. STREET 2: STE. 1503 CITY: SEATTLE STATE: WA ZIP: 98101 D 1 primary_doc.xml X0708 D LIVE 0001632083 Alpine Immune Sciences, Inc. 201 Elliott Ave W Suite 230 SEATTLE WA WASHINGTON 98119 206-441-5064 DELAWARE None None Corporation true 2014 Mitchell H. Gold 201 Elliott Ave W Suite 230 Seattle WA WASHINGTON 98119 Executive Officer Director Jay Venkatesan 201 Elliott Ave W Suite 230 Seattle WA WASHINGTON 98119 Executive Officer Director J. Paul Rickey 201 Elliott Ave W Suite 230 Seattle WA WASHINGTON 98119 Executive Officer Stanford Pang 201 Elliott Ave W Suite 230 Seattle WA WASHINGTON 98119 Executive Officer James Topper 601 Union Street Suite 3200 Seattle WA WASHINGTON 98101 Director Peter Thompson 601 Lexington Ave 54th Floor New York NY NEW YORK 10022 Director Biotechnology Decline to Disclose 06b false 2017-07-24 false true true The proposed merger between Alpine Immune Sciences, Inc. and Nautilus Merger Sub, Inc. (a wholly owned subsidiary of Nivalis Therapeutics, Inc.) is conditioned upon, among other things, the closing of this offering. 0 17000004 17000004 0 false 3 0 0 0 false Alpine Immune Sciences, Inc. /J. Paul Rickey/ J. Paul Rickey Chief Financial Officer 2017-07-24